MS4A1 eiwit (N-TrxA, menselijk)

MS4A1

B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7

N-TrxA

> 80 % as determined by SDS-PAGE.

1.Loaded Obinutuzumab derived anti-Human CD20 antibody, human IgG1 on ProA Biosensor, can bind Recombinant Human CD20 Protein, TrxA Tag, Biotinylated (Cat. No. 11007-H34E-B) with an affinity constant of 14.6 nM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested) . 2.5e5 of anti-CD20 (Rituximab derived) CAR-293 cells were incubated with biotinylated Human CD20 Protein (TrxA Tag) (Cat. No. 11007-H34E-B), and then stained with PE-conjugated Streptavidin. Non-transduced 293 cells were used as a control (left) . PE signal was used to evaluate the binding activity (Routinely tested) . 3.5e5 of anti-CD20 (Obinutuzumab derived) CAR-293 cells were incubated with biotinylated Human CD20 Protein (TrxA Tag) (Cat. No. 11007-H34E-B), and then stained with PE-conjugated Streptavidin. Non-transduced 293 cells were used as a control (left) . PE signal was used to evaluate the binding activity (Routinely tested) .

Ile141-Ser188

The recombinant human MS4A1 consists of 218 amino acids and predicts a molecular mass of 23.9 kDa.

Human